172 related articles for article (PubMed ID: 10404926)
21. Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation?
Beyth RJ; Antani MR; Covinsky KE; Miller DG; Chren MM; Quinn LM; Landefeld CS
J Gen Intern Med; 1996 Dec; 11(12):721-8. PubMed ID: 9016418
[TBL] [Abstract][Full Text] [Related]
22. Sex differences and similarities in the management and outcome of stroke patients.
Holroyd-Leduc JM; Kapral MK; Austin PC; Tu JV
Stroke; 2000 Aug; 31(8):1833-7. PubMed ID: 10926943
[TBL] [Abstract][Full Text] [Related]
23. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.
Levine SR; Brey RL; Tilley BC; Thompson JL; Sacco RL; Sciacca RR; Murphy A; Lu Y; Costigan TM; Rhine C; Levin B; Triplett DA; Mohr JP;
JAMA; 2004 Feb; 291(5):576-84. PubMed ID: 14762036
[TBL] [Abstract][Full Text] [Related]
24. A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO).
Rash A; Downes T; Portner R; Yeo WW; Morgan N; Channer KS
Age Ageing; 2007 Mar; 36(2):151-6. PubMed ID: 17175564
[TBL] [Abstract][Full Text] [Related]
25. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.
Simes J; Becattini C; Agnelli G; Eikelboom JW; Kirby AC; Mister R; Prandoni P; Brighton TA;
Circulation; 2014 Sep; 130(13):1062-71. PubMed ID: 25156992
[TBL] [Abstract][Full Text] [Related]
26. Effect of New Oral Anticoagulants on Prescribing Practices for Atrial Fibrillation in Older Adults.
Fohtung RB; Novak E; Rich MW
J Am Geriatr Soc; 2017 Nov; 65(11):2405-2412. PubMed ID: 28832920
[TBL] [Abstract][Full Text] [Related]
27. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
Arch Intern Med; 1996 Feb; 156(4):409-16. PubMed ID: 8607726
[TBL] [Abstract][Full Text] [Related]
28. Warfarin versus aspirin for prevention of stroke in heart failure: a meta-analysis of randomized controlled clinical trials.
Kumar G; Goyal MK
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1279-87. PubMed ID: 23182364
[TBL] [Abstract][Full Text] [Related]
29. [Atrial fibrillation and apoplexy--risks and prevention].
Koefoed BG; Gulløv AL; Petersen P
Nord Med; 1996 Jun; 111(6):171-5. PubMed ID: 8700641
[TBL] [Abstract][Full Text] [Related]
30. Antithrombotic prescribing in atrial fibrillation: application of a prescribing indicator and multidisciplinary feedback to improve prescribing.
Elliott RA; Woodward MC; Oborne CA
Age Ageing; 2002 Sep; 31(5):391-6. PubMed ID: 12242203
[TBL] [Abstract][Full Text] [Related]
31. Warfarin use in nursing home residents: results from the 2004 national nursing home survey.
Ghaswalla PK; Harpe SE; Slattum PW
Am J Geriatr Pharmacother; 2012 Feb; 10(1):25-36.e2. PubMed ID: 22226690
[TBL] [Abstract][Full Text] [Related]
32. Warfarin versus aspirin in the elderly in primary prophylaxis for atrial fibrillation.
Morrison CM; Gainsborough N; Rajkumar C
Age Ageing; 2007 Mar; 36(2):117-9. PubMed ID: 17255089
[No Abstract] [Full Text] [Related]
33. Low Use of Oral Anticoagulant Prescribing for Secondary Stroke Prevention: Results From the Ontario Stroke Registry.
Shah R; Li S; Stamplecoski M; Kapral MK
Med Care; 2016 Oct; 54(10):907-12. PubMed ID: 27367867
[TBL] [Abstract][Full Text] [Related]
34. Warfarin sodium or aspirin therapy to prevent stroke in nonrheumatic atrial fibrillation. Answered and unanswered questions.
Stratton JR
West J Med; 1995 Aug; 163(2):177-9. PubMed ID: 7571577
[No Abstract] [Full Text] [Related]
35. Cost Effectiveness of Apixaban versus Warfarin or Aspirin for Stroke Prevention in Patients with Atrial Fibrillation: A Greek Perspective.
Athanasakis K; Boubouchairopoulou N; Karampli E; Tarantilis F; Savvari P; Bilitou A; Kyriopoulos J
Am J Cardiovasc Drugs; 2017 Apr; 17(2):123-133. PubMed ID: 27882517
[TBL] [Abstract][Full Text] [Related]
36. Atrial anatomy in non-cardioembolic stroke patients: effect of medical therapy.
Homma S; Sacco RL; Di Tullio MR; Sciacca RR; Mohr JP
J Am Coll Cardiol; 2003 Sep; 42(6):1066-72. PubMed ID: 13678932
[TBL] [Abstract][Full Text] [Related]
37. Underuse of aspirin for secondary prevention of vascular disease.
Mollison LC; James-Wallace MJ; Kirke AB; Stein GR; Jamrozik KD
Med J Aust; 1999 Apr; 170(7):339, 341. PubMed ID: 10327982
[No Abstract] [Full Text] [Related]
38. The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life.
Gage BF; Cardinalli AB; Owens DK
Arch Intern Med; 1996 Sep; 156(16):1829-36. PubMed ID: 8790077
[TBL] [Abstract][Full Text] [Related]
39. US national survey of physician practices for the secondary and tertiary prevention of ischemic stroke. Design, service availability, and common practices.
Goldstein LB; Bonito AJ; Matchar DB; Duncan PW; DeFriese GH; Oddone EZ; Paul JE; Akin DR; Samsa GP
Stroke; 1995 Sep; 26(9):1607-15. PubMed ID: 7660407
[TBL] [Abstract][Full Text] [Related]
40. Warfarin, aspirin, and atrial fibrillation.
Harv Heart Lett; 1998 Aug; 8(12):4-6. PubMed ID: 9713234
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
